symbol,statement_type,period_end,line_item,value
POLYMED.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-906061000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,10003513000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-3310254000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,End Cash Position,86988000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
POLYMED.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,120531000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,-33543000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,9505058000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-112515000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-303409000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,10003513000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,10003513000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,85854000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,85854000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-11942794000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,
POLYMED.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,126701000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,24128000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-8797173000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-3296450000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,13804000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-3310254000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,2404193000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-924121000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,-1543186000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,103691000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,-105028000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Payable,-72788000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-645423000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-837525000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-88499000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Provisionand Write Offof Assets,31755000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,831822000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
POLYMED.NS,cashflow,2025-03-31 00:00:00,Depreciation,831822000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Pension And Employee Benefit Expense,12240000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-377292000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-13994000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-1203000.0
POLYMED.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,4525151000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,-109337000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,2638000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-2770159000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,End Cash Position,120531000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
POLYMED.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,70624000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,49907000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-201535000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-110240000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-287400000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,2638000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,2638000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,211196000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,211196000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-2409380000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,
POLYMED.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,131770000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,5426000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,204420000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-2750996000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,19163000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-2770159000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,2660822000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-743013000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-406570000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,91273000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-47241000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Payable,37615000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-123756000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-366856000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-56724000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Provisionand Write Offof Assets,11262000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,639265000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,34911000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Depreciation,639265000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Pension And Employee Benefit Expense,21144000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-209488000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-18077000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-6228000.0
POLYMED.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,3442691000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-482228000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,3513000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-2392748000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,End Cash Position,70624000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,77574000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-6949000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-125053000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-84575000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-239730000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,3513000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,3513000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,209899000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,209899000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-1792416000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,-1000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,15831000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,5386000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,577638000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-2391271000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,1477000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-2392748000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,1910520000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-578669000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,-494597000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,157044000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,-11261000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Payable,37692000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-402905000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-287968000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,-26773000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Provisionand Write Offof Assets,5939000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,571668000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,29194000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Depreciation,542474000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Pension And Employee Benefit Expense,19274000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,40069000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,17545000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,-1003000.0
POLYMED.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,2374914000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,-321055000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,989000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-1555777000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,End Cash Position,77574000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,1000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,49546000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,28027000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-353379000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-40996000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-239156000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,989000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,989000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,-62816000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,-62816000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-853316000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,
POLYMED.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,38700000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,3189000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,645432000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-1540637000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,15140000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-1555777000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,1234722000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-474560000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-633944000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,119269000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,-80250000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Payable,247015000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-418823000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-507356000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,-110665000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Provisionand Write Offof Assets,308000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,539522000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,26784000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Depreciation,512738000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Pension And Employee Benefit Expense,9310000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-101210000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-24526000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,-5305000.0
POLYMED.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,1952449000.0
POLYMED.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
POLYMED.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-1000.0
POLYMED.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,-3444285000.0
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Provisionand Write Offof Assets,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,24988000.0
POLYMED.NS,cashflow,2021-03-31 00:00:00,Depreciation,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Pension And Employee Benefit Expense,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
POLYMED.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
